Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.13 -0.02 (-1.95%)
As of: Oct 23, 2026 · 1:30 PM EDT

Sonoma Pharmaceuticals (SNOA) Return on Assets [ROA] (2011 - 2026)

Updated

Sonoma Pharmaceuticals' Return on Assets [ROA] came in at -14.12% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 11.01 percentage points from -25.14% a year earlier and up 8.90 percentage points from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Sonoma Pharmaceuticals' Return on Assets [ROA] was -22.96%, up 1.35 percentage points from FY2025.

  • Return on Assets [ROA] carries a five-year change of +3.77 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Assets [ROA] was -24.32% in FY2025 (+6.91 pp), -31.22% in FY2024 (-1.85 pp), -29.37% in FY2023 (+0.70 pp) and -30.07% in FY2022 (-3.33 pp).
  • The fiscal Q1 2027 figure represents the highest quarterly Return on Assets [ROA] since fiscal Q3 2021.
  • Year-over-year, Return on Assets [ROA] has increased for 11 consecutive quarters, with an average year-over-year change of +7.06 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q2 2025 (a gain of 14.70 percentage points), and the weakest in fiscal Q2 2022 (a drop of 18.87 percentage points).
  • Business Quant data shows SNOA's Return on Assets [ROA] at -23.02% (Q4 2026), -24.53% (Q3 2026) and -24.46% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Thermo Fisher Scientific 248.62 Bn 227.65 Bn 4.88 Bn 6.17%
2 Abbott Laboratories 179.72 Bn 150.15 Bn 7.27 Bn 4.94%
3 Danaher 160.69 Bn 144.50 Bn 3.61 Bn 4.54%
4 Intuitive Surgical 158.63 Bn 138.92 Bn 2.08 Bn 14.78%
5 Medtronic 122.80 Bn 88.05 Bn 6.34 Bn 5.66%
6 Stryker 117.90 Bn 104.01 Bn 4.50 Bn -1.94%
7 Boston Scientific 66.70 Bn 61.46 Bn 3.85 Bn 8.19%
8 Becton Dickinson 54.67 Bn 51.82 Bn 2.32 Bn 1.85%
9 Edwards Lifesciences 51.71 Bn 35.72 Bn 1.35 Bn 7.38%
10 Sonoma Pharmaceuticals 4.34 Mn -9.00 Mn 2.58 Mn -14.12%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.12%
Mar 31, 2026 -23.02%
Dec 31, 2025 -24.53%
Sep 30, 2025 -24.46%
Jun 30, 2025 -25.14%
Mar 31, 2025 -25.27%
Dec 31, 2024 -27.40%
Sep 30, 2024 -26.95%
Jun 30, 2024 -32.10%
Mar 31, 2024 -32.94%
Dec 31, 2023 -35.93%
Sep 30, 2023 -41.65%
Jun 30, 2023 -35.38%
Mar 31, 2023 -34.16%
Dec 31, 2022 -46.99%
Sep 30, 2022 -36.06%
Jun 30, 2022 -27.08%
Mar 31, 2022 -26.63%
Dec 31, 2021 -29.62%
Sep 30, 2021 -32.45%
API Access

Sonoma Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SNOA&period=max&api_key=YOUR_API_KEY